Tenet Healthcare Corporation (THC)
NYSE: THC · Real-Time Price · USD
191.86
-3.60 (-1.84%)
At close: Mar 27, 2026, 4:00 PM EDT
192.19
+0.33 (0.17%)
After-hours: Mar 27, 2026, 7:11 PM EDT
Tenet Healthcare Analyst Ratings
Total Analysts
21
Consensus Rating
Buy
Price Target
$237.90
Upside
+24.00%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Maintains $271 → $283 | Strong Buy | Maintains | $271 → $283 | +47.50% | Mar 12, 2026 |
| Mizuho | Mizuho | Buy Maintains $235 → $265 | Buy | Maintains | $235 → $265 | +38.12% | Mar 12, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $255 → $264 | Buy | Maintains | $255 → $264 | +37.60% | Feb 20, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $240 → $270 | Strong Buy | Maintains | $240 → $270 | +40.73% | Feb 17, 2026 |
| Barclays | Barclays | Buy Maintains $240 → $257 | Buy | Maintains | $240 → $257 | +33.95% | Feb 13, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $257 → $271 | Strong Buy | Maintains | $257 → $271 | +41.25% | Feb 13, 2026 |
| Jefferies | Jefferies | Strong Buy Maintains $250 → $265 | Strong Buy | Maintains | $250 → $265 | +38.12% | Feb 12, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $253 → $277 | Buy | Maintains | $253 → $277 | +44.38% | Feb 12, 2026 |
| UBS | UBS | Strong Buy Maintains $260 → $288 | Strong Buy | Maintains | $260 → $288 | +50.11% | Feb 12, 2026 |
| Keybanc | Keybanc | Buy Maintains $225 → $250 | Buy | Maintains | $225 → $250 | +30.30% | Feb 12, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $252 → $253 | Buy | Maintains | $252 → $253 | +31.87% | Feb 3, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $252 → $229 | Buy | Maintains | $252 → $229 | +19.36% | Jan 7, 2026 |
| TD Cowen | TD Cowen | Strong Buy Maintains $233 → $230 | Strong Buy | Maintains | $233 → $230 | +19.88% | Jan 7, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $238 → $257 | Strong Buy | Maintains | $238 → $257 | +33.95% | Dec 2, 2025 |
| Barclays | Barclays | Buy Maintains $229 → $240 | Buy | Maintains | $229 → $240 | +25.09% | Nov 21, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $200 → $230 | Buy | Maintains | $200 → $230 | +19.88% | Nov 13, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.